Prospective Comparative Analysis of ACDF vs Fusion Interbody Cages With nanoLOCK Osseointegrative Technology
Launched by UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER · Feb 27, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Aim 1: Examine the effect of nanoLOCK technology on rates of postoperative dysphagia after ACDF.
Aim 2: Evaluate the effect of nanoLOCK technology on radiographic fusion.
Aim 3: Evaluate how nanoLOCK technology influences the development of radiographic adjacent segment disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Subjects 18 years of age or older
- • Subjects undergoing ACDF surgery for degenerative pathology (one, two or three levels)
- • Subjects with no prior history of cervical spine surgery
- • Subjects with complete/usable data
- Exclusion Criteria:
- • Subjects under the age of 18
- • Subjects not undergoing ACDF surgery
- • Subjects with prior cervical spine surgery
- • Subjects with cervical neoplastic or infectious disease pathology
- • Subjects with cervical trauma pathology
- • ACDF performed at C2-3
- • Subjects with incomplete/unusable data
About University Of Texas Southwestern Medical Center
The University of Texas Southwestern Medical Center is a leading academic medical institution dedicated to advancing healthcare through innovative research, education, and clinical excellence. With a strong emphasis on translational medicine, the center conducts cutting-edge clinical trials aimed at developing novel therapies and improving patient outcomes across a wide range of diseases. Its multidisciplinary approach leverages a collaborative network of renowned faculty, state-of-the-art facilities, and a commitment to ethical research practices, positioning UT Southwestern at the forefront of medical discovery and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dallas, Texas, United States
Patients applied
Trial Officials
Salah Aoun, MD
Principal Investigator
UT Southwestern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials